SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000059478-19-000278
Filing Date
2019-10-25
Accepted
2019-10-25 11:54:53
Documents
84
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lly-9302019x10q.htm   iXBRL 10-Q 3333745
2 EXHIBIT 31.1 lly-9302019x10qex311.htm EX-31.1 13565
3 EXHIBIT 31.2 lly-9302019x10qex312.htm EX-31.2 13572
4 EXHIBIT 32 lly-9302019x10qex32.htm EX-32 11072
  Complete submission text file 0000059478-19-000278.txt   14282576

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lly-20190930.xsd EX-101.SCH 61562
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lly-20190930_cal.xml EX-101.CAL 110784
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lly-20190930_def.xml EX-101.DEF 353706
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lly-20190930_lab.xml EX-101.LAB 799692
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lly-20190930_pre.xml EX-101.PRE 498665
18 EXTRACTED XBRL INSTANCE DOCUMENT lly-9302019x10q_htm.xml XML 3779579
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
LILLY ELI & CO (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06351 | Film No.: 191168729
SIC: 2834 Pharmaceutical Preparations